Kiara Reju 2.2ml Skin Booster
Class III Medical Device | Manufacturer: BioPlus Co., Ltd. (South Korea)
Professional-grade dermal bio-revitalization formulation. Engineered for structural tissue matrix repair, stratum corneum hydration retention, and accelerated fibroblast proliferation.
Active Formulation Data
5 mg/ml PDRN
Polydeoxyribonucleotide
Extracted from salmon milt. Upregulates VEGF (Vascular Endothelial Growth Factor), stimulating angiogenesis and accelerating physiological DNA synthesis in damaged dermal layers.
20 mg/ml HA
Hyaluronic Acid (1500 kDa)
High molecular weight, non-cross-linked structure. Restores extracellular matrix hydration, providing a volumetric structural scaffold for continuous 8-hour cellular moisture retention.
1 mg/ml Niacinamide
Stabilized Vitamin B3
Inhibits melanosome transfer to keratinocytes. Clinically proven to reduce transepidermal water loss (TEWL) and stabilize the epidermal lipid barrier function.
Clinical Trial Efficacy
In vivo testing metrics derived from a double-blind, placebo-controlled study on 85 female subjects over a 12-week evaluation period.
Citation: Journal of Cosmetic Dermatology (2022); 21(3): 145-152. “Efficacy of combined PDRN and non-cross-linked HA in facial rejuvenation.”
+ 72.4%
Stratum Corneum Hydration Retention (Week 4)
– 46.8%
Periorbital Rhytid Depth Reduction (Week 12)
+ 31.2%
Dermal Density Increase via Ultrasound (Week 12)
Clinical Application Protocol
Injection Parameters
Depth: Superficial to mid-dermis (1.0mm – 2.0mm)
Gauge: 30G or 32G (4mm)
Technique: Micro-papule or Nappage
Dosage: 0.05ml per injection point
Treatment Schedule
Initial Course: 3 to 4 sessions
Interval: 14 days between sessions
Maintenance: 1 session every 3 to 6 months
Storage & Handling
Volume: 3 x 2.2ml per box
Temperature: 1°C to 30°C
Constraint: UV-sensitive. Do not freeze.
Important Safety Information
Strictly limited to licensed medical practitioners and certified dermal clinicians.
This product is a professional medical device, but not evaluated by the for unapproved indications. Contraindicated for patients with known hypersensitivity to hyaluronic acid, salmon-derived DNA, active autoimmune disorders, or during pregnancy and lactation. Mandatory comprehensive medical history review and localized patch testing required prior to initial administration.

Reviews
There are no reviews yet.